Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 3/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA5A | P35218 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | UTRN | P46939 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CFTR | P13569 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28943711 | 0.97 | L3MBTL1 (0.56) | L3MBTL1ALDH1A1MEN1KMT2ACA2 | |
| Oxirane SCHEMBL31453069 | 0.89 | L3MBTL1 (0.48) | L3MBTL1ALDH1A1MEN1KMT2ACA2 | |
| SCHEMBL471980 | 0.89 | HPGD (0.52) | L3MBTL1ALDH1A1MEN1KMT2ACA2 | |
| SCHEMBL29159686 | 0.89 | L3MBTL1 (0.48) | L3MBTL1ALDH1A1MEN1KMT2ACA2 | |
| SCHEMBL28702854 | 0.87 | HPGD (0.50) | L3MBTL1ALDH1A1MEN1KMT2ACA2 | |
| SCHEMBL27467881 | 0.87 | L3MBTL1 (0.47) | L3MBTL1ALDH1A1MEN1KMT2ACA2 | |
| SCHEMBL31472733 | 0.87 | PKM (0.54) | L3MBTL1ALDH1A1MEN1KMT2ACA2 | |
| SCHEMBL916596 | 0.87 | ESR1 (0.64) | L3MBTL1ALDH1A1MEN1KMT2ACA2 | |
| SCHEMBL29023907 | 0.87 | L3MBTL1 (0.55) | L3MBTL1ALDH1A1MEN1KMT2ACA2 | |
| SCHEMBL28448234 | 0.86 | UTRN (0.46) | L3MBTL1ALDH1A1MEN1KMT2ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 839 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025060129-A1 | AMMONIUM DIHYDROCARBYLPHOSPHINATE AND PREPARATION METHOD THEREFOR AND USE THEREOF | 江苏利思德新材料股份有限公司 | 2025-03-27 | — | — | WO | claimed |
| CN-117263974-A | Dialkyl phosphinic acid ammonium salt and preparation method and application thereof | 江苏利思德新材料股份有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-110885674-A | Composite material and preparation method thereof | TCL集团股份有限公司 | 2020-03-17 | — | — | CN | claimed |
| US-8633127-B2 | Selective hydrogenation catalyst and methods of making and using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-01-21 | — | — | US | claimed |
| US-8293862-B2 | Polyester polymerization catalyst, polyester produced by using the same, and a process for producing polyester | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2012-10-23 | — | — | US | claimed |
| US-20070149757-A1 | POLYESTER POLYMERIZATION CATALYST, POLYESTER PRODUCED BY USING THE SAME, AND A PROCESS FOR PRODUCING POLYESTER | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2007-06-28 | — | — | US | claimed |
| CN-1238423-C | Thermoplastic resin composition and molded object thereof | POLYPLASTICS CO (JP) | 2006-01-25 | — | — | CN | claimed |
| WO-2002076968-A1 | MALONATES AS INHIBITORS OF THE ICE/CED-6 FAMILY OF CYSTEINE PROTEASES | NOVARTIS AG (CH) | 2002-10-03 | — | — | WO | claimed |
| EP-0803508-B1 | Process for the preparation of aluminium salts of phosphinic acids | TICONA GMBH (DE) | 2001-10-10 | — | — | EP | claimed |
| US-5869722-A | Process for producing aluminum phosphinates | TICONA GMBH (DE) | 1999-02-09 | — | — | US | claimed |
| EP-0803508-A1 | Process for the preparation of aluminium salts of phosphinic acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-10-29 | — | — | EP | claimed |
| US-4853153-A | USING REDUCING AGENT AND CHLORINATED CYCLIC KETONE | RHONE-POULENC CHIMIE (FR) | 1989-08-01 | — | — | US | claimed |
| EP-4745198-A1 | RESIN COMPOSITION, MOLDED ARTICLE, RESIN ADDITIVE COMPOSITION, METHOD FOR PRODUCING RESIN COMPOSITION, METHOD FOR IMPROVING CRYSTALLINITY OF CRYSTALLINE RESIN, AND MATERIAL FOR RESIN ADDITIVE COMPOSITION | ADEKA CORPORATION (JP) | 2026-05-20 | — | — | EP | disclosed |
| US-20260117009-A1 | UV CURABLE PROTECTIVE MATERIAL COMPOSITION WITH EXCELLENT FLAME RETARDANCY AND LED DISPLAY USING THE SAME | O FLEX CO LTD (KR) | 2026-04-30 | — | — | US | disclosed |
| WO-2026090281-A1 | POLYESTER COMPOSITIONS COMPRISING AMORPHOUS COPOLYESTER HAVING HIGH GLASS TRANSITION TEMPERATURE AND ARTICLES MADE THEREFROM | EASTMAN CHEMICAL COMPANY (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026090275-A1 | POLARIZER PROTECTION FILMS COMPRISING AMORPHOUS COPOLYESTER COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 2026-04-30 | — | — | WO | disclosed |
| US-4377537-A | FROM TRIARYL PHOSPHITE AND ALKYL PHOSPHITE OR PHOSPHONOUS ACID DIARYL ESTER AND PHOSPHONOUS ACID DIALKYL ESTER | BAYER AKTIENGESELLSCHAFT (DE) | 1983-03-22 | — | — | US | disclosed |
| US-4269977-A | Process for the manufacture of 8-oxo-5-thia-1-azabicyclo [4,2,0]oct-2-ene or 3-ene compounds | CIBA-GEIGY CORPORATION (US) | 1981-05-26 | — | — | US | disclosed |
| US-4067927-A | TEXTILES | STAUFFER CHEMICAL COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
| US-4017257-A | Textiles fire-retardant treated with copolycondensed vinylphosphonates and process | STAUFFER CHEMICAL COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117009-A1 | UV CURABLE PROTECTIVE MATERIAL COMPOSITION WITH EXCELLENT FLAME RETARDANCY AND LED DISPLAY USING THE SAME | PFN1, PFAS, ULK1 | L3MBTL1 2251/4885ALDH1A1 1417/4885MEN1 1552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.